Southern Strategic Sourcing Partners (S3P) 2022 All Member Clinical Supply Conference
This session is geared towards providing educational insight into the unprecedented changes underway in emerging market healthcare and how to translate these changes into strategic and operational planning tools that span the health care system financial and business model optimization; clinical operational effectiveness; service line site-of-care optimization and patient-centric sustainability and reliability across the continuum for inpatient and outpatient care. Additionally, this presentation will address the need for focused awareness on clinical operations improvement and the relevance in mitigating hospital acquired conditions and the associated financial penalties.
Let’s Save Our Patients! National Trends, Future States and Successful Intervention in Acquired Conditions and Complications – 1.00 contact hour – Rick May and Rick Beaver
Discuss unprecedented emerging market trends in the changing healthcare landscape.
Discuss clinical operations improvement and the relevance in mitigating hospital acquired conditions and the associated financial penalties
Discuss impact on top of license clinical staffing and impact on productivity optimization and clinical quality patient experience
Gene Replacement Therapy- A look inside the impact to pharmacotherapy – 1.00 contact hour – Emily Diehl
Identify types of gene therapy and the impact on the genome
Distinguish gene therapy’s application to the genetic disorder
Categorize the pharmacy department impact and implementation obstacles
Describe storage and handling concerns with gene therapy
Support effective practices for storing, handling and distributing gene therapy
Optimizing the 340B Drug Discount Program in an Evolving Regulatory Landscape – 1.00 contact hour – Greg Medley
Discuss the pharmacy department impact and implementation obstacles
Discuss recent trends related to reporting requirements, reimbursement rates and pricing.
Discuss key challenges impacting health system pharmacies' ability to optimize the 340B Drug Discount.
2021 Impact of Change Forecast Highlights: Covid-19 Impact Recovery and Impact on Utilization – 1.00 contact hour – Jeff Moser
Discuss Care Shifts and the implications on resourcing to anticipate the changing landscape of Inpatient Care
Discuss the importance of building a strategy to deliver care in the appropriate location
Relevant financial relationships: Planning committee members have nothing to disclose. Emily Diehl will discuss off-label use of drugs.
Planning committee members
Kristen Allen, MSN
Sr. Director, Strategic Sourcing Partnerships & Programs
Rosa Byrd, MSN, RN
Director, Cardiac Cath Lab
Michael McLemore, RN BSN
(Vizient Approved Nurse Planner)
Mitch Brown, PharmD
Pharmacy Executive Director
Rick May, MS, MD
Orthopedic Trauma Surgeon
Sr. Principal, Performance Improvement
Rick Beaver, BS, MBB, CPHQ
AVP, Performance Improvement
Greg Medley, PharmD
Pharmacy Sr. Director
Emily Diehl, PharmD
Pharmacy Executive Director
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is designated for 4.00 contact hours.
Vizient, Inc. designates this activity for a maximum of 4.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-118-L04-P
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
- 4.00 ACPE Pharmacist
- 4.00 ANCC
- 4.00 General CEU – Attendance